EditCo Draughts & Discoveries | Cambridge, UK
Driving Drug Development with Genome Editing at AstraZeneca
Watch Now
EditCo Draughts & Discoveries | Cambridge, UK
Antisense Oligonucleotide Depletion of CCDC146 is a Broad-spectrum Therapeutic Strategy for ALS
Watch Now
EditCo Draughts & Discoveries | Cambridge, UK
Leveraging EditCo Gene Knockout tools in High-Throughput Arrayed CRISPR Screens
Watch Now
EditCo Draughts & Discoveries | Cambridge, UK
Exploring Protein Biology Through Endogenous HiBiT Tagging
Watch Now
EditCo Draughts & Discoveries | Cambridge, UK
Scaling complexity: arrayed CRISPR screens for immune target discovery
Watch Now
HiBiT-Tagged Knock-In
From Edit to Insight: Faster Drug Discovery with HiBiT-Enabled Screens
Watch Now
XDel CRISPR Technology
Uncovering Novel Cancer Therapeutic Targets: Accelerating Discovery Through Streamlined CRISPR Cell Engineering
Watch Now
iPS Cells
Advancing Neuroinflammation Research with iPSC-Derived Microglia and Automated Assays for Drug Discovery
Watch Now
Partnered with Evariste and Arctoris' Ulysses®
AI-driven identification and validation of novel synthetic lethal gene pairs
Watch Now
Partnered with IDEXX BioAnalytics
Ensuring Cell Health for Optimal Research Outcomes and Successful CRISPR Gene Editing Experiments
Watch Now